Please login or register first to view this content.
Cardiovascular Disease Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Real-World Antihypertensive Prescribing Deviates From Guidelines, Study Says
USPSTF Finds Evidence Lacking for Vitamin D Screening
AHA Issues Statement on Drug-Induced Arrhythmias
EPA, DHA Supplementation Linked to Reduced Risk for MI, CHD
Eplerenone May Improve Albumin Excretion in T2D With Acceptable Safety
Risk of Cardiac Events With Azithromycin, Amoxicillin Compared
Empagliflozin Fast Tracked for Improving Outcomes Following Myocardial Infarction
NIH Launches Clinical Trials of Antithrombotics for COVID-19
Risk of Aortic Aneurysm, Dissection With Fluoroquinolones Examined
CYP2C19 Genotyping May Aid Antiplatelet Prescribing
Early Therapy for Rheumatoid Arthritis May Slow Heart Disease
Dapagliflozin Reduces Hyperkalemia Risk in Heart Failure Treated With MRAs
Antihypertensive Drugs and Cancer Risk: Is There a Link?
In-Hospital Heart Failure Deaths Down With Routine Vaccinations
Empagliflozin Beneficial in Heart Failure With Reduced Ejection Fraction
Label Mix-Up Prompts Recall of IV Amiodarone, Tranexamic Acid
Evolocumab Cuts LDL-C in Pediatric HeFH Patients
Hyponatremia in Heart Failure Linked to High-Dose Furosemide, Spironolactone
